Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4791 Target Snapshot

Endothelin-converting enzyme 1 · SINGLE PROTEIN · Homo sapiens

526Compounds
70Assays
0Approved Drugs
501.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Endothelin-converting enzyme 1 shows clinical signal disease relevance led by hypertension. 1 linked drug keeps the current disease frame grounded. Protein identity stays anchored to UniProt P42892. Start with hypertension, then reuse UniProt P42892 as the stable protein anchor across project notes and exports.

Review focus
Review-ready target frame

Start with hypertension, then reuse UniProt P42892 as the stable protein anchor across project notes and exports.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14 1 linked drug
Open source guide
Disease program
hypertension

Endothelin-converting enzyme 1 shows clinical signal disease relevance led by hypertension. 1 linked drug remains visible in the same block.

Start review with hypertension because it currently carries clinical signal support. Linked drugs include DAGLUTRIL. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.

Disease source · ChEMBL drug mechanism + indication proxy
Clinical signal Open Targets-ready proxy 1 linked drug
Open disease block
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Endothelin-converting enzyme 1 as ChEMBL target CHEMBL4791, mapped to UniProt P42892. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Endothelin-converting enzyme 1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL4791
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P42892
Endothelin-converting enzyme 1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Endothelin-converting enzyme 1 is the right protein anchor across sources, using UniProt P42892 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need to confirm why hypertension is currently framed as clinical signal support. It currently carries 1 linked drug in the same disease frame.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelEndothelin-converting enzyme 1
UniProt AccessionP42892
Component TypeProtein
Sequence Length770 aa

Endothelin-converting enzyme 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Endothelin-converting enzyme 1, mapped to UniProt P42892. Sequence length is 770 aa.

Mapped IDP42892
Review nameEndothelin-converting enzyme 1
OrganismHomo sapiens
Disease Relevance

Disease Relevance & Evidence Level

Open Targets-ready disease context using the current target-indication evidence contract.

Clinical signal Open Targets-ready proxy

Endothelin-converting enzyme 1 shows clinical signal disease relevance led by hypertension.

Clinical signal Phase II
hypertension
1 linked drug · 1 direct · 1 efficacy
Linked drugDAGLUTRIL
Source · ChEMBL drug mechanism + indication proxy
Review Cue

How to read disease relevance

Start review with hypertension because it currently carries clinical signal support. Linked drugs include DAGLUTRIL. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.

Lead diseasehypertension
Strongest levelClinical signal
Block modeOpen Targets-ready proxy
Clinical Profile

Clinical Phase Distribution

1
Phase II
Assay Mix

Activity Type Distribution

IC50436.0
KI65.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL66284 11.0 IC50 0.01 Preclinical
CHEMBL66967 9.7 IC50 0.2 Preclinical
CHEMBL303159 9.6 IC50 0.25 Preclinical
CHEMBL479579 9.1 IC50 0.8 Preclinical
CHEMBL571153 8.92 Ki 1.2 Preclinical
CHEMBL63317 8.92 IC50 1.2 Preclinical
CHEMBL147964 8.59 IC50 2.6 Preclinical
CHEMBL304939 8.52 IC50 3.0 Preclinical
CHEMBL303892 8.32 IC50 4.8 Preclinical
CHEMBL148056 8.22 IC50 6.0 Preclinical
Distribution

pChEMBL Value Distribution

39
5.0
42
5.5
68
6.0
89
6.5
70
7.0
53
7.5
16
8.0
4
8.5
1
9.0
2
9.5
pChEMBL
Assay Landscape

Assay Landscape

70
Total Assays
372
Tested Compounds
3
Assay Types
Binding — 68 assays, 372 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 50 219 6.7
cell-based format 10 98 6.1
tissue-based format 6 41 6.5
assay format 2 14 6.6
ADME — 1 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 1 1
Functional — 1 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 1 5.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine